Products & Technologies

In anticipation that follow-on biologics may soon become a reality and an increasing demand for process development and contract clinical manufacturing services, ScinoPharm Taiwan has established the capability to develop a number of recombinant proteins and monoclonal antibodies and, through contract, has access to a newly constructed Taiwan government cGMP biotech facility for our production needs.

Biopharmaceutical products and processes under development

The following recombinant proteins and monoclonal antibodies are in various stages of development

• Interferon Alpha-2b/PEGylated Interferon Alpha-2b
• Interferon Beta 1a and 1b
• Human Growth Hormone (met-HGH)
• Erythropoietin
• Human Granulocyte Colony-Stimulating Factor (G-CSF)/PEGylated G-CSF
• Tumor Necrosis Factor Receptor Fusion Protein ( TNFR:Fc )
• Recombinant Aprotinin
• Vascular Endothelial Growth Factor (VEGF)
• Brain Derived Neurotrophic Factor (BDNF)
• Humanized Monoclonal Antibodies

We can now provide materials for research use for most of the above protein therapeutics. For more information, please contact us at Spb.oligo@scinopharm.com.tw